Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
201851-13-0	(1S,2S)-4-methoxybenzyl 2-((S)-4-((9H-xanthen-9-yl)methyl)-1-(4-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)cyclopropanecarboxylate COC1=CC=C(C=C1)CN2C(=O)C(NC2=O)(CC3C4=CC=CC=C4OC5=CC=CC=C35)C6CC6C(=O)OC7=CC=C(C=C7)OC	C₃₆H₃₂N₂O₇	604.6	98%	Click to inquire
201943-63-7	2-[(1s,2s)-2-Carboxycyclopropyl]-3-(9h-Xanthen-9-Yl)-D-Alanine C1C(C1C(CC2C3=CC=CC=C3OC4=CC=CC=C24)(C(=O)O)N)C(=O)O	C₂₀H₁₉NO₅	353.4	98%	Click to inquire
20197-72-2	2-Amino-4,5-diethoxybenzoic acid CCOC1=C(C=C(C(=C1)C(=O)O)N)OCC	C₁₁H₁₅NO₄	225.24	98%	Click to inquire
202189-78-4	Bilastine CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O	C₂₈H₃₇N₃O₃	463.6	99%	Click to inquire
202350-68-3	Pnu-159682 CC1C2C(CC(O1)OC3CC(CC4=C3C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=CC=C6)OC)O)(C(=O)CO)O)N7CCOC(C7O2)OC	C₃₂H₃₅NO₁₃	641.6	95%	Click to inquire
202592-24-3	6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, (6R)- CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)O)C4=CC=C(C=C4)Cl)C	C₁₉H₁₇ClN₄O₂S	400.9	98%	Click to inquire
202857-89-4	2-(Benzyloxy)-4-fluorobenzaldehyde C1=CC=C(C=C1)COC2=C(C=CC(=C2)F)C=O	C₁₄H₁₁FO₂	230.23	98%	Click to inquire
202917-17-7	Glucagon receptor antagonists 3 CCCC1=C(NC(=C(C1C2=C(C=C(C=C2)F)O)C(C)O)C(C)C)C(C)C	C₂₂H₃₂FNO₂	361.5	95%	Click to inquire
202917-18-8	Glucagon receptor antagonists 2 CCCC1=C(NC(=C(C1C2=C(C=C(C=C2)F)O)C(C)O)C(C)C)C(C)C	C₂₂H₃₂FNO₂	361.5	92%	Click to inquire
203209-15-8	Cyclopropanecarboxylic acid, 2-[(4R)-1-[(4-methoxyphenyl)methyl]-2,5-dioxo-4-(9H-xanthen-9-ylmethyl)-4-imidazolidinyl]-, (4-methoxyphenyl)methyl ester, (1S,2S)- COC1=CC=C(C=C1)CN2C(=O)C(NC2=O)(CC3C4=CC=CC=C4OC5=CC=CC=C35)C6CC6C(=O)OCC7=CC=C(C=C7)OC	C₃₇H₃₄N₂O₇	618.7	98%	Click to inquire

(1S,2S)-4-methoxybenzyl 2-((S)-4-((9H-xanthen-9-yl)methyl)-1-(4-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)cyclopropanecarboxylate

(1S,2S)-4-methoxybenzyl 2-((S)-4-((9H-xanthen-9-yl)methyl)-1-(4-methoxybenzyl)-2,5-dioxoimidazolidin-4-yl)cyclopropanecarboxylat

C₃₆H₃₂N₂O₇ 604.6

2-[(1s,2s)-2-Carboxycyclopropyl]-3-(9h-Xanthen-9-Yl)-D-Alanine

C₂₀H₁₉NO₅ 353.4

2-Amino-4,5-diethoxybenzoic acid

6-AMINO-3,4-DIETHOXYBENZOIC ACID

C₁₁H₁₅NO₄ 225.24

C₂₈H₃₇N₃O₃ 463.6

C₃₂H₃₅NO₁₃ 641.6

6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetic acid, 4-(4-chlorophenyl)-2,3,9-trimethyl-, (6R)-

（—）JQ-1 acid

C₁₉H₁₇ClN₄O₂S 400.9

2-(Benzyloxy)-4-fluorobenzaldehyde

2-Benzyloxy-4-fluorobenzaldehyde

C₁₄H₁₁FO₂ 230.23

Glucagon receptor antagonists 3

Glucagon receptor antagonists-3

C₂₂H₃₂FNO₂ 361.5

Glucagon receptor antagonists 2

Glucagon receptor antagonists-2

C₂₂H₃₂FNO₂ 361.5

Cyclopropanecarboxylic acid, 2-[(4R)-1-[(4-methoxyphenyl)methyl]-2,5-dioxo-4-(9H-xanthen-9-ylmethyl)-4-imidazolidinyl]-, (4-methoxyphenyl)methyl ester, (1S,2S)-

Cyclopropanecarboxylic acid, 2-[(4R)-1-[(4-methoxyphenyl)methyl]-2,5-dioxo-4-(9H-xanthen-9-ylmethyl)-4-imidazolidinyl]-, (4-meth

C₃₇H₃₄N₂O₇ 618.7

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15316) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号